CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- IR Summary of Consolidated Financial Results for the Three Months Ended March 31, 2021 (J-GAAP)
- Others Bridge Report the fiscal year 2020
- Others Company Brochure – Fiscal Year 2020, “With You CellSeed Vol. 13”
- IR Fiscal 2020 Earnings Results Presentation
- IR Mid-term Business Plan Fiscal Year 2021 to Fiscal Year 2023